Evidence map›Paper›PMID 24420771›Full record

ArticleThe Journal of general physiology2014

Catalyst-like modulation of transition states for CFTR channel opening and closing: new stimulation strategy exploits nonequilibrium gating.

László Csanády, Beáta Töröcsik

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of general physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Structural mechanisms of CFTR function and dysfunction.The Journal of general physiology · 2018
    Review
  5. Molecular modelling and molecular dynamics of CFTR.Cellular and molecular life sciences : CMLS · 2017
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Modulation of CFTR gating by permeant ions.The Journal of general physiology · 2015
    Article
  11. Article
  12. Putative chanzyme activity of TRPM2 cation channel is unrelated to pore gating.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

László CsanádyDepartment of Medical Biochemistry and 2 MTA-SE Ion Channel Research Group, Semmelweis University, Budapest H-1094, Hungary.
Beáta Töröcsik
Semmelweis University · HU

Funding

MECHANISMS, STRUCTURE, AND REGULATION OF CFTR'S NBFSR01DK051767 · NIDDK · ROCKEFELLER UNIVERSITY · PI GADSBY, DAVID C · 1996 to 2014
$4.9M
Howard Hughes Medical InstituteNIDDK NIH HHS R01 DK051767NIDDK NIH HHS R01-DK051767
6 · The paper itself

Abstract

Cystic fibrosis transmembrane conductance regulator (CFTR) is the chloride ion channel mutated in cystic fibrosis (CF) patients. It is an ATP-binding cassette protein, and its resulting cyclic nonequilibrium gating mechanism sets it apart from most other ion channels. The most common CF mutation (ΔF508) impairs folding of CFTR but also channel gating, reducing open probability (Po). This gating defect must be addressed to effectively treat CF. Combining single-channel and macroscopic current measurements in inside-out patches, we show here that the two effects of 5-nitro-2-(3-phenylpropylamino)benzoate (NPPB) on CFTR, pore block and gating stimulation, are independent, suggesting action at distinct sites. Furthermore, detailed kinetic analysis revealed that NPPB potently increases Po, also of ΔF508 CFTR, by affecting the stability of gating transition states. This finding is unexpected, because for most ion channels, which gate at equilibrium, altering transition-state stabilities has no effect on Po; rather, agonists usually stimulate by stabilizing open states. Our results highlight how for CFTR, because of its unique cyclic mechanism, gating transition states determine Po and offer strategic targets for potentiator compounds to achieve maximal efficacy.

Indexed as

AnimalsCatalysisCystic Fibrosis Transmembrane Conductance RegulatorFemaleHumansIon Channel GatingNitrobenzoatesXenopus laevis5-nitro-2-(3-phenylpropylamino)benzoic acidCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorNitrobenzoates

Identifiers

PMID24420771
PMCPMC4001772
OpenAlexW2102781109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.